BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16713537)

  • 1. An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.
    Lupu CM; Eisenbach C; Kuefner MA; Schmidt J; Lupu AD; Stremmel W; Encke J
    J Gastrointest Surg; 2006 May; 10(5):635-45. PubMed ID: 16713537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice.
    Sivanandham M; Shaw P; Bernik SF; Paoletti E; Wallack MK
    Cancer Immunol Immunother; 1998 Jul; 46(5):261-7. PubMed ID: 9690454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral B7-H3 therapy induces tumor specific immune responses and reduces secondary metastasis in a murine model of colon cancer.
    Lupu CM; Eisenbach C; Lupu AD; Kuefner MA; Hoyler B; Stremmel W; Encke J
    Oncol Rep; 2007 Sep; 18(3):745-8. PubMed ID: 17671729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains.
    Pan WY; Lo CH; Chen CC; Wu PY; Roffler SR; Shyue SK; Tao MH
    Mol Ther; 2012 May; 20(5):927-37. PubMed ID: 22334018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of B7.1-transfected human colon cancer cells on the induction of autologous tumour-specific cytotoxic T cells.
    Miyazono Y; Kamogawa Y; Ryo K; Furukawa T; Mitsuhashi M; Yamauchi K; Kameoka T; Hayashi N
    J Gastroenterol Hepatol; 1999 Oct; 14(10):997-1003. PubMed ID: 10530496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
    Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.
    Rao JB; Chamberlain RS; Bronte V; Carroll MW; Irvine KR; Moss B; Rosenberg SA; Restifo NP
    J Immunol; 1996 May; 156(9):3357-65. PubMed ID: 8617961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent antitumor activity of interleukin-27.
    Hisada M; Kamiya S; Fujita K; Belladonna ML; Aoki T; Koyanagi Y; Mizuguchi J; Yoshimoto T
    Cancer Res; 2004 Feb; 64(3):1152-6. PubMed ID: 14871851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
    Liu A; Hu P; Khawli LA; Epstein AL
    Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with mouse mammary adenocarcinoma cells coexpressing B7-1 (CD80) and B7-2 (CD86) discloses the dominant effect of B7-1 in the induction of antitumor immunity.
    Martín-Fontecha A; Moro M; Crosti MC; Veglia F; Casorati G; Dellabona P
    J Immunol; 2000 Jan; 164(2):698-704. PubMed ID: 10623812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma.
    Tanaka N; Sivanandham M; Wallack MK
    J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):283-93. PubMed ID: 7881637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12.
    Joki T; Kikuchi T; Akasaki Y; Saitoh S; Abe T; Ohno T
    Int J Cancer; 1999 Aug; 82(5):714-20. PubMed ID: 10417770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
    Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
    Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells.
    Luo L; Chapoval AI; Flies DB; Zhu G; Hirano F; Wang S; Lau JS; Dong H; Tamada K; Flies AS; Liu Y; Chen L
    J Immunol; 2004 Nov; 173(9):5445-50. PubMed ID: 15494491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT.
    Hisada M; Yoshimoto T; Kamiya S; Magami Y; Miyaji H; Yoneto T; Tamada K; Aoki T; Koyanagi Y; Mizuguchi J
    Cancer Gene Ther; 2004 Apr; 11(4):280-8. PubMed ID: 15002032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of membrane anchored cytokines and B7-1 alters tumor microenvironment and induces protective antitumor immunity in a murine breast cancer model.
    Bozeman EN; Cimino-Mathews A; Machiah DK; Patel JM; Krishnamoorthy A; Tien L; Shashidharamurthy R; Selvaraj P
    Vaccine; 2013 May; 31(20):2449-56. PubMed ID: 23541884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of T cell co-regulator factor B7-H3 with
    Burvenich IJG; Parakh S; Lee FT; Guo N; Liu Z; Gan HK; Rigopoulos A; O'Keefe GJ; Gong SJ; Goh YW; Tochon-Danguy H; Scott FE; Kotsuma M; Hirotani K; Senaldi G; Scott AM
    Theranostics; 2018; 8(15):4199-4209. PubMed ID: 30128047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
    Lee JH; Cho ES; Kim MY; Seo YW; Kho DH; Chung IJ; Kook H; Kim NS; Ahn KY; Kim KK
    Cancer Res; 2005 Oct; 65(19):8993-9003. PubMed ID: 16204073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer models.
    Forde PF; Hall LJ; de Kruijf M; Bourke MG; Doddy T; Sadadcharam M; Soden DM
    Gene Ther; 2015 Jan; 22(1):29-39. PubMed ID: 25373914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.